Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Horwitz
    Horwitz
  9. Perales
    Perales
  10. Salles
    Salles

Groups

  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (124)
  3. Research Letter (26)
  4. Editorial (16)
  5. Review (11)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (17)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (353)
  2. Haematologica Meeting Reports (4)

Results (357)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
    Editorial

    Dogan, A.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Patients with hypercortisolemic Cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis
    Journal Article

    Varricchio, L.; Geer, E. B.; Martelli, F.; Mazzarini, M.; Funnell, A.; Bieker, J. J.; Papayannopoulou, T.; Migliaccio, A. R.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: Results from the international SCHOLAR-5 study
    Journal Article

    Ghione, P.; Palomba, M. L.; Ghesquieres, H.; Bobillo, S.; Patel, A. R.; Nahas, M.; Kanters, S.; Deighton, K.; Hatswell, A.; Ma, L.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in diffuse large B-cell lymphoma: Clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm
    Research Letter

    Liu, Y.; Derkach, A.; Lewis, N.; Zhu, M.; Zhang, Y.; Arcila, M.; Salles, G.; Dogan, A.; Xiao, W.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Positron emission tomography-computed tomography before autologous stem cell transplant in follicular lymphoma: Coming too late?
    Editorial

    Sarkozy, C.; Salles, G.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer
    Journal Article

    Petrone, G.; Gaulin, C.; Derkach, A.; Kishtagari, A.; Robson, M. E.; Parameswaran, R.; Stein, E. M.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination
    Research Letter

    Chhabra, S.; Szabo, A.; Clurman, A.; McShane, K.; Waters, N.; Eastwood, D.; Samanas, L.; Fei, T.; Armijo, G.; Abedin, S.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma
    Journal Article

    Usmani, S. Z.; Nahi, H.; Legiec, W.; Grosicki, S.; Vorobyev, V.; Spicka, I.; Hungria, V.; Korenkova, S.; Bahlis, N. J.; Flogegard, M.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: Analysis of 210 patients from the UKALL14 and UKALL60+clinical trials
    Journal Article

    Creasey, T.; Barretta, E.; Ryan, S. L.; Butler, E.; Kirkwood, A. A.; Leongamornlert, D.; Papaemmanuil, E.; Patrick, P.; Clifton-Hadley, L.; Patel, B.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib
    Journal Article

    Mato, A. R.; Tang, B.; Azmi, S.; Yang, K.; Zhang, X.; Stern, J. C.; Hedrick, E.; Huang, J.; Sharman, J. P.
    Haematologica (2022)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: